| Application no. and date | 22702211.8 (espacenet) (Federated) (European Patent Register), 20220121 | | Patent/reg. no. and date | DK/EP 4281448, 20250101 | | Publication date | 20231129 | | Priority no. and date | EP 21153034, 20210122 | | EP pub. no. and date |
EP 4281448 20231129 | | Effective date | | | Applicant/owner | BASF SE, Carl-Bosch-Strasse 38
67056 Ludwigshafen am Rhein, DE | | Applicant ref. no. | | | Inventor | GOETZ, Roland,
67056 Ludwigshafen, DE,
KORADIN, Christopher,
67056 Ludwigshafen, DE,
McLaughlin, Martin John,
4410 Liestal, CH,
GARIVET, Guillaume Michel Jacques,
67056 Ludwigshafen, DE,
SHINDE, Harish,
Mumbai 400705, IN,
KADUSKAR, Rahul,
Mumbai 400705, IN | | Representative | | | Opponent | | | IPC Class | C07D 417/12 (2006.01) | | Title | METHOD FOR PREPARING AN ENANTIOMERICALLY ENRICHED FORM OF 2-[2-(2-CHLOROTHIAZOL-5-YL)-2-HYDROXY-ETHYL]SULFANYL-6-HYDROXY-3-METHYL-5-PHENYL-PYRIMIDIN-4-ONE | | Int. application no. | EP2022051354 | | Int. publication no. | WO2022157316 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
